RE:Matt Pietras CFO background - extensiveImpressive resume and experience here and indicates confidence in SZ.
Of course now we can expect a scathing rant from our local expert 4everposting of of how Mr Pietras has been banished from the healthcare industry, forced out of various positions and left with the only option of employment with Stage. Such is the plight of the board these days..........
LithLover wrote: Quite the bio for Matt Pietras:
He comes to Stagezero from the position of VP of Finance for CiVi Biopharma
CiVi Biopharma is a privately held company that was founded in 2017.
To date, the Company has raised approximately ~$120 million and is supported by leading venture and corporate investors, including Boxer Capital, Tang Capital, Roche Ventures, RA Capital and a leading NYC-based biotechnology investment fund.
---------------
Prior to that he was the Controller at Viela Bio
Viela Bio was a spin off of AstraZeneca and was recently purchased for $3 Billion by Horizon Therapeutics
https://www.biopharmadive.com/news/horizon-acquires-astrazeneca-spinout-viela-bio/594265/
-----------
Prior to Viela Bio he was the Therapeutic Area Finance Director- Oncology at AstraZeneca and Head of Financial Planning at Medimmune (an AstraZeneca company).
---------------
Prior to that he was VP Finance Oversight for 8 years at Wells Fargo Pretty good resume and I'm sure he looked at the future of Stagezero, the Care deal and the financials before he came over to Stagezero. Welcome aboard.